MI
LIMNW

MMCAP International’s Liminatus Pharma Warrants LIMNW Stock Holding History

MMCAP International’s Portfolio LIMNW Stock Details LIMNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.47K Hold
111,745
– – ﹤0.01% 238
2025
Q4 		$3.91K Hold
111,745
– – ﹤0.01% 203
2025
Q3 		$16.5K Hold
111,745
– – ﹤0.01% 150
2025
Q2 		$26.8K Buy
+111,745
New +$22K ﹤0.01% 114

Other funds holding LIMNW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

MMCAP International's LIMNW Position: Q1 2026 in Review

MMCAP International held its Liminatus Pharma Warrants (LIMNW) position steady in Q1 2026 at 111,745 shares worth $4.47K. The position accounts for ﹤0.01% of the portfolio, ranked #238.

MMCAP International first reported a position in LIMNW in Q2 2025 and has held it in 4 quarters since. The position peaked at $26.8K in Q2 2025. 21 funds tracked by Wall St. Rank hold LIMNW as of Q1 2026.

  • MMCAP International held 111,745 shares of Liminatus Pharma Warrants worth $4.47K as of Q1 2026.
  • MMCAP International left its Liminatus Pharma Warrants share count unchanged in Q1 2026.
  • Liminatus Pharma Warrants made up ﹤0.01% of MMCAP International's portfolio in Q1 2026, its #238 holding.
  • MMCAP International first reported a position in Liminatus Pharma Warrants in Q2 2025 and has held it in 4 quarters since.
  • MMCAP International's Liminatus Pharma Warrants position peaked at $26.8K in Q2 2025.
  • 21 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q1 2026.

Based on MMCAP International's 13F filing for Q1 2026, filed 15 May 2026.